Directed evolution of a remarkably efficient Kdnase from a bacterial neuraminidase.
- Published in:
- Glycobiology, 2020, v. 30, n. 5, p. 325, doi. 10.1093/glycob/cwz099
- By:
- Publication type:
- Article
Works matching IS 09596658 AND DT 2020 AND VI 30 AND IP 5
Results: 7
1
2
The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling.
- Published in:
- Glycobiology, 2020, v. 30, n. 5, p. 312, doi. 10.1093/glycob/cwz098
- By:
- Publication type:
- Article
3
Fucoidan suppresses the gastric cancer cell malignant phenotype and production of TGF-β1 via CLEC-2.
- Published in:
- Glycobiology, 2020, v. 30, n. 5, p. 301, doi. 10.1093/glycob/cwz097
- By:
- Publication type:
- Article
4
Modulation of hepatocyte sialylation drives spontaneous fatty liver disease and inflammation.
- Published in:
- Glycobiology, 2020, v. 30, n. 5, p. 346, doi. 10.1093/glycob/cwz096
- By:
- Publication type:
- Article
5
Microarray analyses of closely related glycoforms reveal different accessibilities of glycan determinants on N-glycan branches.
- Published in:
- Glycobiology, 2020, v. 30, n. 5, p. 334, doi. 10.1093/glycob/cwz100
- By:
- Publication type:
- Article
6
Glyco-Forum.
- Published in:
- Glycobiology, 2020, v. 30, n. 5, p. 281, doi. 10.1093/glycob/cwaa031
- Publication type:
- Article
7
Identification of Tn antigen O-GalNAc-expressing glycoproteins in human carcinomas using novel anti-Tn recombinant antibodies.
- Published in:
- Glycobiology, 2020, v. 30, n. 5, p. 282, doi. 10.1093/glycob/cwz095
- By:
- Publication type:
- Article